Perturbation of ATP-induced tetramerization of human cytosolic thymidine kinase by substitution of serine-13 with aspartic acid at the mitotic phosphorylation site. 2004

Chia-Lung Li, and Ching-Yi Lu, and Po-Yuan Ke, and Zee-Fen Chang
Institute of Biochemistry and Molecular Biology, College of Medicine, National Taiwan University, No 1 Jen Ai Road First Section, Taipei, Taiwan ROC.

Human cytosolic thymidine kinase (TK1) is tightly regulated in the cell cycle by multiple mechanisms. Our laboratory has previously shown that in mitotic-arrested cells human TK1 is phosphorylated at serine-13, accompanied by a decrease in catalytic efficiency. In this study we investigated whether serine-13 phosphorylation regulated TK1 activity and found that substitution of serine-13 with aspartic acid (S13D), which mimics phosphorylation, not only diminished the ATP-activating effect on the enzyme, but also decreased its thymidine substrate affinity. Our experimental results further showed that the S13D mutation perturbed ATP-induced tetramerization of TK1. Given that the dimeric form of TK1 is less active than the tetrameric, we propose that mitotic phosphorylation of serine-13 is of physiological importance, in that it may counteract ATP-dependent activation of TK1 by affecting its quaternary structure, thus attenuating its enzymatic function at the G2/M phase.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008938 Mitosis A type of CELL NUCLEUS division by means of which the two daughter nuclei normally receive identical complements of the number of CHROMOSOMES of the somatic cells of the species. M Phase, Mitotic,Mitotic M Phase,M Phases, Mitotic,Mitoses,Mitotic M Phases,Phase, Mitotic M,Phases, Mitotic M
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D010957 Plasmids Extrachromosomal, usually CIRCULAR DNA molecules that are self-replicating and transferable from one organism to another. They are found in a variety of bacterial, archaeal, fungal, algal, and plant species. They are used in GENETIC ENGINEERING as CLONING VECTORS. Episomes,Episome,Plasmid
D002384 Catalysis The facilitation of a chemical reaction by material (catalyst) that is not consumed by the reaction. Catalyses
D002453 Cell Cycle The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE. Cell Division Cycle,Cell Cycles,Cell Division Cycles,Cycle, Cell,Cycle, Cell Division,Cycles, Cell,Cycles, Cell Division,Division Cycle, Cell,Division Cycles, Cell
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002845 Chromatography Techniques used to separate mixtures of substances based on differences in the relative affinities of the substances for mobile and stationary phases. A mobile phase (fluid or gas) passes through a column containing a stationary phase of porous solid or liquid coated on a solid support. Usage is both analytical for small amounts and preparative for bulk amounts. Chromatographies

Related Publications

Chia-Lung Li, and Ching-Yi Lu, and Po-Yuan Ke, and Zee-Fen Chang
May 1998, The Journal of biological chemistry,
Chia-Lung Li, and Ching-Yi Lu, and Po-Yuan Ke, and Zee-Fen Chang
February 2003, The Biochemical journal,
Chia-Lung Li, and Ching-Yi Lu, and Po-Yuan Ke, and Zee-Fen Chang
February 2000, International journal of oncology,
Chia-Lung Li, and Ching-Yi Lu, and Po-Yuan Ke, and Zee-Fen Chang
July 1993, The Journal of biological chemistry,
Chia-Lung Li, and Ching-Yi Lu, and Po-Yuan Ke, and Zee-Fen Chang
December 2001, Neuroreport,
Chia-Lung Li, and Ching-Yi Lu, and Po-Yuan Ke, and Zee-Fen Chang
October 2000, Oncogene,
Chia-Lung Li, and Ching-Yi Lu, and Po-Yuan Ke, and Zee-Fen Chang
July 2001, Journal of immunological methods,
Chia-Lung Li, and Ching-Yi Lu, and Po-Yuan Ke, and Zee-Fen Chang
May 2006, Biochemistry,
Chia-Lung Li, and Ching-Yi Lu, and Po-Yuan Ke, and Zee-Fen Chang
November 1995, Biochemical Society transactions,
Copied contents to your clipboard!